# Labi Exames

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/labi-exames

- Industry: Healthcare
- Headquarters: Sao Paulo, Brazil
- Website: www.labiexames.com.br
- Total disclosed funding: $4.8M
- Latest round: Series A (Sep 24, 2019)
- Investors on record: 1

## About

Labi Exames SA specializes in laboratory services, focusing on diagnostic testing and health assessments for individuals and corporate clients across Brazil.Founded in 2017 in Sao Paulo, Brazil, Labi Exames SA provides laboratory services with a focus on diagnostic testing. The company has undergone no notable pivots or changes in its business operations. Marcelo Barboza serves as both the Founder and CEO. In December 2021, the company raised BRL 20.000 mn in a Series A funding round led by Igah Ventures, bringing the total amount raised to BRL 20.000 mn. Labi Exames SA has completed 3 deals to date, with the most recent deal occurring on December 29, 2021.Labi Exames SA offers a comprehensive suite of laboratory services, primarily focused on diagnostic testing. Their core offerings include a variety of laboratory examinations, health check-ups, and immunobiological medication administration, catering to diverse clinical needs. The company facilitates a user-friendly experience, allowing customers to schedule tests through their health plans without the necessity of a medical order. Clients can opt for in-person services at modern facilities located near metro stations or request home collection services for added convenience. Labi Exames SA serves a broad clientele, including individual patients, corporate employees, and health plan members, primarily across Brazil.In the most recent year, Labi Exames SA reported a revenue of BRL 4,140,734.50 with an EBITDA of -BRL 2,131,053.10.Following the most recent funding round in December 2021, Labi Exames SA plans to further develop its laboratory service offerings and enhance its digital platforms for a more streamlined customer experience. The company is also exploring expansion into new geographic markets within Brazil to reach additional customers by the end of 2023. The funding raised will support these strategic initiatives and assist in the launch of new products aimed at improving health accessibility.

## Funding rounds

- Series A, Sep 24, 2019, $4.8M — Igah Ventures

## Investors

- Igah Ventures (https://capitalatlas.ai/funds/igah-ventures) — Series A